Cargando…

Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes

BACKGROUND: The landscape of smoking cessation may have changed in Europe recently. OBJECTIVES: To identify changes in use of smoking cessation assistance in the European Union (EU) and factors associated with use of cessation assistance. METHODS: Data from the 2012 (n=9921) and 2017 (n=9489) waves...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippidis, Filippos T, Laverty, Anthony A, Mons, Ute, Jimenez-Ruiz, Carlos, Vardavas, Constantine I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317445/
https://www.ncbi.nlm.nih.gov/pubmed/29563220
http://dx.doi.org/10.1136/tobaccocontrol-2017-054117
_version_ 1783384746536992768
author Filippidis, Filippos T
Laverty, Anthony A
Mons, Ute
Jimenez-Ruiz, Carlos
Vardavas, Constantine I
author_facet Filippidis, Filippos T
Laverty, Anthony A
Mons, Ute
Jimenez-Ruiz, Carlos
Vardavas, Constantine I
author_sort Filippidis, Filippos T
collection PubMed
description BACKGROUND: The landscape of smoking cessation may have changed in Europe recently. OBJECTIVES: To identify changes in use of smoking cessation assistance in the European Union (EU) and factors associated with use of cessation assistance. METHODS: Data from the 2012 (n=9921) and 2017 (n=9489) waves of the Eurobarometer survey were used. Self-reported use of smoking cessation assistance was assessed among smokers who had ever tried to quit and former smokers. Changes in use of each type of assistance were assessed using logistic regression. RESULTS: Among current and former smokers, those who had ever attempted to quit without assistance increased from 70.3% (2012) to 74.8% (2017). Current smokers were more likely to have used any assistance compared with former smokers (P<0.001). Use of e-cigarettes for smoking cessation assistance increased (3.7% to 9.7%)%), while use of pharmacotherapy (14.6% to 11.1%)%) and smoking cessation services (7.5% to 5.0%)%) declined. Younger people were more likely to have reported e-cigarette use for smoking cessation but less likely to have used a cessation service. Individuals living in countries with comprehensive smoking cessation policies were more likely to have used any cessation assistance (adjusted OR (aOR)=1.78; 95% CI 1.15 to 2.76), pharmacotherapy (aOR=3.44; 95% CI 1.78 to 6.66) and smoking cessation services (aOR=2.27; 95% CI 1.27 to 4.06) compared with those living in countries with weak smoking cessation policies. CONCLUSIONS: These findings highlight the need for approaches that ensure that smokers get support to quit smoking across the EU. The question of whether the availability of e-cigarettes will displace other methods, and the impact of such a displacement, should be closely evaluated.
format Online
Article
Text
id pubmed-6317445
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-63174452019-01-04 Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes Filippidis, Filippos T Laverty, Anthony A Mons, Ute Jimenez-Ruiz, Carlos Vardavas, Constantine I Tob Control Research Paper BACKGROUND: The landscape of smoking cessation may have changed in Europe recently. OBJECTIVES: To identify changes in use of smoking cessation assistance in the European Union (EU) and factors associated with use of cessation assistance. METHODS: Data from the 2012 (n=9921) and 2017 (n=9489) waves of the Eurobarometer survey were used. Self-reported use of smoking cessation assistance was assessed among smokers who had ever tried to quit and former smokers. Changes in use of each type of assistance were assessed using logistic regression. RESULTS: Among current and former smokers, those who had ever attempted to quit without assistance increased from 70.3% (2012) to 74.8% (2017). Current smokers were more likely to have used any assistance compared with former smokers (P<0.001). Use of e-cigarettes for smoking cessation assistance increased (3.7% to 9.7%)%), while use of pharmacotherapy (14.6% to 11.1%)%) and smoking cessation services (7.5% to 5.0%)%) declined. Younger people were more likely to have reported e-cigarette use for smoking cessation but less likely to have used a cessation service. Individuals living in countries with comprehensive smoking cessation policies were more likely to have used any cessation assistance (adjusted OR (aOR)=1.78; 95% CI 1.15 to 2.76), pharmacotherapy (aOR=3.44; 95% CI 1.78 to 6.66) and smoking cessation services (aOR=2.27; 95% CI 1.27 to 4.06) compared with those living in countries with weak smoking cessation policies. CONCLUSIONS: These findings highlight the need for approaches that ensure that smokers get support to quit smoking across the EU. The question of whether the availability of e-cigarettes will displace other methods, and the impact of such a displacement, should be closely evaluated. BMJ Publishing Group 2019-01 2018-03-21 /pmc/articles/PMC6317445/ /pubmed/29563220 http://dx.doi.org/10.1136/tobaccocontrol-2017-054117 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Paper
Filippidis, Filippos T
Laverty, Anthony A
Mons, Ute
Jimenez-Ruiz, Carlos
Vardavas, Constantine I
Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title_full Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title_fullStr Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title_full_unstemmed Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title_short Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
title_sort changes in smoking cessation assistance in the european union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317445/
https://www.ncbi.nlm.nih.gov/pubmed/29563220
http://dx.doi.org/10.1136/tobaccocontrol-2017-054117
work_keys_str_mv AT filippidisfilippost changesinsmokingcessationassistanceintheeuropeanunionbetween2012and2017pharmacotherapyversuscounsellingversusecigarettes
AT lavertyanthonya changesinsmokingcessationassistanceintheeuropeanunionbetween2012and2017pharmacotherapyversuscounsellingversusecigarettes
AT monsute changesinsmokingcessationassistanceintheeuropeanunionbetween2012and2017pharmacotherapyversuscounsellingversusecigarettes
AT jimenezruizcarlos changesinsmokingcessationassistanceintheeuropeanunionbetween2012and2017pharmacotherapyversuscounsellingversusecigarettes
AT vardavasconstantinei changesinsmokingcessationassistanceintheeuropeanunionbetween2012and2017pharmacotherapyversuscounsellingversusecigarettes